Skip to Content
U.S. Healthcare Compliance Certificate Program

Healthcare Compliance Training - United States Program

U.S. Healthcare Compliance Certificate Program

[email protected] | 973-642-8382 or 973-761-9000 ext. 8382


PROGRAM SCHEDULED for June 2-5, 2025 | In-Person
PROGRAM SCHEDULED for October 6-9, 2025 | In-Person/Hybrid

Agenda Below - All Times in Eastern Standard Time

Day 1 - June 2, 2025

 

Ethics; Transparency; Diversity, Equity & Inclusion; Government Pricing; and FDA Regulation

8:30 - 9:00am 

Registration & Breakfast

9:00 - 9:20

Welcome, Program Introduction & Format Review

Rosa Alves

Rosa M. Alves

Assistant Dean for Global Compliance & Programming, Seton Hall Law School

Learn more about Rosa M. Alves

Jacob Elberg

Jacob T. Elberg

Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School

Learn more about Jacob T. Elberg 

9:25 - 10:15

The Relationship Between Ethics and Legal Compliance

Jacob Elberg

Jacob T. Elberg

Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School

Learn more about Jacob T. Elberg 

10:15 - 10:35

Break

10:35 - 12:00

Navigating State, Federal & International Transparency Disclosure Requirements

Audrey F. DeGuarde

Audrey F. DeGuarde

Vice President of Compliance Operations, RLDatix Life Sciences (formerly Porzio Life Sciences)

Learn more about Audrey F. DeGuarde

12:00 - 1:00

Lunch Break

1:00 - 2:00

Diversity, Equity and Inclusion in the Compliance Industry

Shirell Gross

Shirell A. Gross

Vice President and Global Chief Counsel for Global Operations & Supply Chain, Medtronic

Learn more about Shirell A. Gross

Sunita Patel

Sunita Patel

Counsel, Bristol Myers Squibb

Learn more about Sunita Patel 

Jacob T. Elberg

Moderator: Jacob T. Elberg

Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School

Learn more about Jacob T. Elberg 

2:15 - 3:30

Government Pricing Regulation: Key Issues for Compliance Professionals

Kathleen Peterson

Kathleen Peterson

Counsel, Global Regulatory, Hogan Lovells

Learn more about Kathleen Peterson

3:30 - 3:50

Break

3:50 - 5:00

Track 1 (Rodino Reading Room): FDA Regulation of Drug Development & Approval 

Matthew Hegreness

Matthew Hegreness

Partner, Covington & Burling LLP

Learn more about Matthew Hegreness 

3:50 - 5:00

Track 2 (Room 370): Overview of U.S. Medical Device Regulation

Scott Danzis

Scott Danzis

Partner, Covington & Burling LLP

Learn more about Scott Danzis

 

Day 2 - Tuesday, June 3, 2025

 

False Claims Act; Foreign Corrupt Practices Act; Case Study; and Compliance Officers’ Panel

8:30 - 9:00

Registration & Breakfast

9:00 - 10:15

The False Claims Act and Dealing with Whistleblowers

Meredith Auten

Meredith Auten

Partner, Morgan, Lewis & Bockius LLP

Learn more about Meredith Auten

Pamela Coyle Brecht

Pamela Coyle Brecht

Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP

Learn more about Pamela Coyle Brecht

10:15 - 10:30

Break

10:30 - 11:45

The Foreign Corrupt Practices Act (and World-Wide Anti-Corruption Enforcement) 

Gary Giampetruzzi

Gary Giampetruzzi

Partner, Litigation Department, Paul Hastings LLP

Learn more about Gary Giampetruzzi

March Coleman

March Coleman

AVP, Ethics & Compliance, Merck

Learn more about March Coleman

11:45 - 12:45 

Lunch Break

12:45 - 2:15

Compliance Case Study Workshop: Break-Out Sessions

2:20 - 3:25

Compliance Case Study Workshop: Break-Out Sessions & Workshop

Regina Gore Cavaliere

Regina Gore Cavaliere

Vice President, Regulatory & Compliance, Chief
Ethics & Compliance Officer, Henry Schein, Inc. 

Learn more about Regina Gore Cavaliere 

Christie Camelio

Christie Camelio

Sr. VP, Chief Compliance Officer, Insmed

Learn more about Christie Camelio

Michael "Mickey" Kim

Michael “Mickey” Kim

Global Chief Compliance Officer, HOYA Medtech and Life Science Segment Company

Learn more about Michael “Mickey” Kim  

Jennifer McGee

Jennifer McGee

Sr. VP & Global Chief Compliance Officer (Ret.), Otsuka Pharmaceutical

Learn more about Jennifer McGee 

3:25 - 3:45 

Break

3:45 - 5:00

Compliance Officers' Panel Discussion

Regina Gore Cavaliere

Regina Gore Cavaliere

Vice President, Regulatory & Compliance, Chief
Ethics & Compliance Officer, Henry Schein, Inc. 

Learn more about Regina Gore Cavaliere

Christie Camelio

Christie Camelio

Sr. VP, Chief Compliance Officer, Insmed

Learn more about Christie Camelio 

Michael "Mickey" Kim

Michael “Mickey” Kim

Global Chief Compliance Officer, HOYA Medtech and Life Science Segment Company

Learn more about Michael “Mickey” Kim

Jennifer McGee

Jennifer McGee

Sr. VP & Global Chief Compliance Officer (Ret.), Otsuka Pharmaceutical

Learn more about Jennifer McGee

Jacob T. Elberg

Moderator: Jacob T. Elberg

Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School

Learn more about Jacob T. Elberg 

5:00 - 6:30 

Cocktail Reception – Café Deni

 

Day 3 - June 4, 2025

 

Data Analytics; Anti-Kickback Statute; Advertising & Promotion; Federal Health Care Programs; and Privacy & Data Protection

8:30 - 9:00

Registration & Breakfast

9:00 - 9:55 

Data Analytics

Stacy Aiken

Stacy Aiken

Sr. Director, Enterprise Risk Management BPO, Johnson & Johnson

Michael Driscoll

Michael Driscoll

Managing Member, Driscoll & DeSimone, LLC & Former, Director, Global Strategic Insights, Health Care Compliance, Johnson & Johnson

Learn more about Michael Driscoll

Jacob T. Elberg

Jacob T. Elberg

Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School

Learn more about Jacob T. Elberg 

9:55 - 10:10

Break

10:10 - 11:25

The Federal Anti-Kickback Statute 

Bruce Levy

Bruce Levy

Partner, Hartmann Doherty Rosa Berman & Bulbulia

Learn more about Bruce Levy

11:30 - 12:45

Prescription Drug & Medical Device Advertising/Scientific & Educational Activities

Gillian M. Russell

Gillian M. Russell

Counsel, FDA & Life Sciences, King & Spalding LLP

Learn more about Gillian M. Russell

12:45 - 1:45

Lunch Break

1:45 - 2:55

An Overview of Federal and Private Health Care Programs for Drug and Device Manufacturers

Philo D. Hall

Philo D. Hall

Member of the Firm, Epstein Becker & Green, P.C.

Learn more about Philo D. Hall

3:00 - 4:15 

Topics in U.S. Privacy and Data Protection: Pharmaceutical and Biotech Considerations

Jeremy Berkowitz

Jeremy Berkowitz

Sr. Privacy Director & Deputy Chief Privacy Officer, Paul Hastings LLP

Learn more about Jeremy Berkowitz

4:15 - 4:30 

Refreshments

 

Day 4 - Thursday, June 5, 2025

 

Corporate Integrity Agreements; and Speaker Programs; Codes of Ethics; Health Care Fraud Enforcement, and Investigations

8:30 - 9:00

Registration & Breakfast

9:00 - 10:05 

Compliance Lessons Learned from Corporate Integrity Agreements

Brian Bohnenkamp

Brian Bohnenkamp

Partner, FDA & Life Sciences, King & Spalding LLP

Learn more about Brian Bohnenkamp 

10:05 - 10:25 

Break

10:25 - 11:15

Compliance Risks Associated with Speaker Programs

Adam Baker

Adam Baker

Partner, Special Matters & Government Investigations, King & Spalding LLP

Learn more about Adam Baker

Craig Carpenito

Craig Carpenito

Partner, Special Matters & Government Investigations, King & Spalding LLP

Learn more about Craig Carpenito 

11:20 - 12:30

AdvaMed v. PhRMA: Comparing Codes of Ethics on Interactions with Health Care Professionals

Katie C. Pawlitz

Katie C. Pawlitz

Partner, Reed Smith LLP

Learn more about Katie C. Pawlitz 

12:30 - 1:30

Lunch Break

1:30 - 2:30 

Recent Developments in Federal Healthcare Fraud Prosecution and the Value of Compliance and Cooperation

Joshua L. Haber

Joshua L. Haber

Chief of the Criminal Division, U.S. Attorney’s Office for the District of New Jersey

Learn more about Joshua L. Haber

2:35 - 3:30

Panel Discussion: Being the Focus of a Government Investigation

Joshua L. Haber

Joshua L. Haber

Chief of the Criminal Division, U.S. Attorney’s Office for the District of New Jersey

Learn more about Joshua L. Haber 

Jane H. Yoon

Jane H. Yoon

Partner, Litigation Department, Paul Hastings LLP

Learn more about Jane H. Yoon 

John Kelly

John Kelly

Partner & Chair of the Healthcare Department and Industry
Practice, Barnes & Thornburg LLP

Learn more about John Kelly

Blank

Katie Holden

Federal Bureau of Investigation, Newark Field Office

Timothy Glynn

Moderator: Timothy Glynn

Andrea J. Catania Endowed Professor of Law, Seton Hall Law School

Learn more about Timothy Glynn

3:30 - 4:00 

Concluding Remarks

4:00 

Grab & Go Refreshments